\Market by Product, Application, End-user, and Country | Forecast 2019-2028
Triton’s research on the Europe neurorehabilitation device market depicts that it will grow at a CAGR of 14.31% in terms of revenue during the forecast period 2019-2028.
Report scope can be customized per your requirements. Request For Customization
The countries evaluated in
this market are:
• The United Kingdom
• Germany
• France
• Spain
• Italy
• Russia
• Rest of Europe countries
Neurorehabilitation devices
mainly find application in the healthcare sector; this includes
hospitals/clinics, cognitive care centers, and research institutes. The
neurorehabilitation device market in Europe is expected to be on a rising
trend, owing to the high prevalence of Alzheimer’s disease and stroke and the
growing geriatric population. Along with this, the growing government
investments in research for neurodegenerative disease and a rise in the number
of newly developed centers for neurorehabilitation are also adding to the
market growth. In addition, strategies adopted by various industry players for
marketing and expansion are expected to boost the European neurorehabilitation
device market in the coming years.
According to recent data, the
number of 40- to 59-year-olds in Germany is 23.9 million people at present.
They account for the largest age group in terms of population in the country.
Further, most recent figures confirm that the next-largest age group by
population in the country is comprised of people aged 65 years and older, at
17.88 million. The population above 60 years of age is more likely to suffer
from neurological disorders like Alzheimer’s diseases, dementia, and
Parkinson’s diseases. Thus, the rapidly growing geriatric population is
expected to generate demand for neurorehabilitation devices in Germany.
Moreover, numerous market players are adopting growth strategies, such as
product launches. This is expected to further propel the market in an upward
direction. Therefore, factors like a rapidly rising elderly population and
strategies adopted by several market players are fueling the growth of
Germany’s neurorehabilitation device market.
Tyromotion manufactures and
distributes computer- and robot-assisted therapy units for the rehabilitation
sector. The company has a wide portfolio comprising upper extremity
rehabilitation products. In addition, their therapy software provides feedback
and measurement modules for rehabilitation. In addition, it has collaborated
with Hankamp Rehab, Ectron, Elite Medical, and BEKA RUS for the distribution of
its products. The company was established in 2007, and is based in Austria.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. EUROPE
NEUROREHABILITATION DEVICE MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. PORTER’S
FIVE FORCES MODEL
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTE PRODUCTS
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. COMPETITIVE
RIVALRY
2.3. SUPPLY
CHAIN OUTLOOK
2.4. IMPACT
OF CORONAVIRUS ON NEUROREHABILITATION DEVICE MARKET
2.5. ETYMOLOGY
OF NEUROREHABILITATION DEVICE
2.6. KEY
IMPACT ANALYSIS
2.7. MARKET
ATTRACTIVENESS INDEX
2.8. KEY
INSIGHTS
2.9. MARKET
DRIVERS
2.9.1. RISE
IN GERIATRIC POPULATION
2.9.2. GROWING
EMERGENCE OF NEUROREHABILITATION WEARABLES AND ROBOTICS
2.9.3. RISING
PREVALENCE OF NEUROLOGICAL DISEASES
2.10.MARKET RESTRAINTS
2.10.1. LACK OF SKILLED WORKFORCE TO TREAT AND MANAGE
NEUROLOGICAL DISEASES
2.10.2. HIGH COST OF TREATMENT
2.11.MARKET OPPORTUNITIES
2.11.1. ADVANCEMENTS IN TECHNOLOGY
2.11.2. RISING INCIDENCE OF NEUROLOGICAL DISORDERS IN
DEVELOPING ECONOMIES
2.12.MARKET CHALLENGES
2.12.1.STRINGENT GOVERNMENT REGULATIONS
3. NEUREHABILITATION
DEVICE MARKET OUTLOOK - BY PRODUCT
3.1. NEURO-ROBOTIC
SYSTEM
3.2. BRAIN-COMPUTER
INTERFACE
3.3. WEARABLE
DEVICE
3.4. NON-INVASIVE
STIMULATOR
3.5. OTHER
PRODUCTS
4. NEUREHABILITATION
DEVICE MARKET OUTLOOK - BY APPLICATION
4.1. STROKE
4.2. CEREBRAL
PALSY
4.3. PARKINSON’S
DISEASE
4.4. MULTIPLE
SCLEROSIS
4.5. OTHER
APPLICATIONS
5. NEUREHABILITATION
DEVICE MARKET OUTLOOK - BY END-USER
5.1. HOSPITAL/CLINIC
5.2. RESEARCH
INSTITUTE
5.3. COGNITIVE
CARE CENTER
5.4. OTHER
END-USER
6. NEUREHABILITATION
DEVICE MARKET – EUROPE
6.1. COUNTRY
ANALYSIS
6.1.1. GERMANY
6.1.2. FRANCE
6.1.3. THE
UNITED KINGDOM
6.1.4. ITALY
6.1.5. RUSSIA
6.1.6. SPAIN
6.1.7. REST
OF EUROPE
7. COMPANY
PROFILES
7.1. BIONIK
LABORATORIES CORP
7.2. TYROMOTION
GMBH
7.3. BIOXTREME
7.4. ECTRON
LIMITED
7.5. KINOVA
7.6. ABBOTT
LABORATORIES
7.7. BIOMETRICS
LTD
7.8. REHA
TECHNOLOGY AG
7.9. MEDTRONIC
INC
7.10. HELIUS MEDICAL TECHNOLOGIES
7.11.HOKOMA AG
7.12. KINESTICA
7.13.SAEBO
7.14.NEUROSTYLE PTE LTD
7.15.EKSO BIONICS HOLDINGS INC
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.1.1. OBJECTIVES
OF STUDY
8.1.2. SCOPE
OF STUDY
8.2. SOURCES
OF DATA
8.2.1. PRIMARY
DATA SOURCES
8.2.2. SECONDARY
DATA SOURCES
8.3. RESEARCH
METHODOLOGY
8.3.1. EVALUATION
OF PROPOSED MARKET
8.3.2. IDENTIFICATION
OF DATA SOURCES
8.3.3. ASSESSMENT
OF MARKET DETERMINANTS
8.3.4. DATA
COLLECTION
8.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1 EUROPE NEUROREHABILITATION DEVICE MARKET, BY COUNTRY,
2019-2028 (IN $ MILLION)
TABLE 2 EUROPE NEUROREHABILITATION DEVICE MARKET, BY PRODUCT,
2019-2028 (IN $ MILLION)
TABLE 3 EUROPE NEUROREHABILITATION DEVICE MARKET, BY APPLICATION,
2019-2028 (IN $ MILLION)
TABLE 4 EUROPE NEUROREHABILITATION DEVICE MARKET, BY END-USER,
2019-2028 (IN $ MILLION)
TABLE 5 EUROPE NEUROREHABILITATION DEVICE MARKET, BY COUNTRY,
2019-2028 (IN $ MILLION)
FIGURE 1 EUROPE NEUROREHABILITATION DEVICE MARKET
2019-2028 (IN $ MILLION)
FIGURE 2 SUPPLY CHAIN OUTLOOK FOR
NEUROREHABILITATION DEVICE MARKET
FIGURE 3 ETYMOLOGY OF NEUROREHABILITATION DEVICE
MARKET
FIGURE 4 EUROPE NEUROREHABILITATION DEVICE MARKET,
BY NEURO-ROBOTIC SYSTEM, 2019-2028 (IN $ MILLION)
FIGURE 5 EUROPE NEUROREHABILITATION DEVICE MARKET,
BY BRAIN-COMPUTER INTERFACE, 2019-2028 (IN $ MILLION)
FIGURE 6 EUROPE NEUROREHABILITATION DEVICE MARKET,
BY WEARABLE DEVICE, 2019-2028 (IN $ MILLION)
FIGURE 7 EUROPE NEUROREHABILITATION DEVICE MARKET,
BY NON-INVASIVE STIMULATOR, 2019-2028 (IN $ MILLION)
FIGURE 8 EUROPE NEUROREHABILITATION DEVICE MARKET,
BY OTHER PRODUCTS, 2019-2028 (IN $ MILLION)
FIGURE 9 EUROPE NEUROREHABILITATION DEVICE MARKET,
BY STROKE, 2019-2028 (IN $ MILLION)
FIGURE 10 EUROPE NEUROREHABILITATION DEVICE MARKET, BY
CEREBRAL PALSY, 2019-2028 (IN $ MILLION)
FIGURE 11 EUROPE NEUROREHABILITATION DEVICE MARKET, BY
PARKINSON’S DISEASE, 2019-2028 (IN $ MILLION)
FIGURE 12 EUROPE NEUROREHABILITATION DEVICE MARKET, BY
MULTIPLE SCLEROSIS, 2019-2028 (IN $ MILLION)
FIGURE 13 EUROPE NEUROREHABILITATION DEVICE MARKET, BY
OTHER APPLICATIONS, 2019-2028 (IN $ MILLION)
FIGURE 14 EUROPE NEUROREHABILITATION DEVICE MARKET, BY
HOSPITAL/CLINIC, 2019-2028 (IN $ MILLION)
FIGURE 15 EUROPE NEUROREHABILITATION DEVICE MARKET, BY
RESEARCH INSTITUTE, 2019-2028 (IN $ MILLION)
FIGURE 16 EUROPE NEUROREHABILITATION DEVICE MARKET, BY
COGNITIVE CARE CENTER, 2019-2028 (IN $ MILLION)
FIGURE 17 EUROPE NEUROREHABILITATION DEVICE MARKET, BY
OTHER END-USER, 2019-2028 (IN $ MILLION)
FIGURE 18 GERMANY NEUROREHABILITATION DEVICE MARKET
2019-2028 (IN $ MILLION)
FIGURE 19 FRANCE NEUROREHABILITATION DEVICE MARKET
2019-2028 (IN $ MILLION)
FIGURE 20 THE UNITED KINGDOM NEUROREHABILITATION DEVICE
MARKET 2019-2028 (IN $ MILLION)
FIGURE 21 ITALY NEUROREHABILITATION DEVICE MARKET
2019-2028 (IN $ MILLION)
FIGURE 22 RUSSIA NEUROREHABILITATION DEVICE MARKET
2019-2028 (IN $ MILLION)
FIGURE 23 SPAIN NEUROREHABILITATION DEVICE MARKET
2019-2028 (IN $ MILLION)
FIGURE 24 REST OF EUROPE NEUROREHABILITATION DEVICE
MARKET 2019-2028 (IN $ MILLION)